[HTML][HTML] Gene therapy progress and prospects: cancer gene therapy using tumour suppressor genes

IA McNeish, SJ Bell, NR Lemoine - Gene therapy, 2004 - nature.com
Targeting tumour suppressor gene pathways is an attractive therapeutic strategy in cancer.
Since the first clinical trial took place in 1996, at least 20 other trials have investigated the …

[HTML][HTML] A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans

GL Bond, W Hu, EE Bond, H Robins, SG Lutzker… - Cell, 2004 - cell.com
The tumor suppressor p53 gene is mutated in minimally half of all cancers. It is therefore
reasonable to assume that naturally occurring polymorphic genetic variants in the p53 stress …

DNA damage, p14ARF, nucleophosmin (NPM/B23), and cancer

RA Gjerset - Journal of molecular histology, 2006 - Springer
Abstract The p53/p14ARF/mdm2 stress response pathway plays a central role in mediating
cellular responses to oncogene activation, genome instability, and therapy-induced DNA …

MDM2 interaction with nuclear corepressor KAP1 contributes to p53 inactivation

C Wang, A Ivanov, L Chen, WJ Fredericks… - The EMBO …, 2005 - embopress.org
MDM2 is a RING domain ubiquitin E3 ligase and a major regulator of the p53 tumor
suppressor. MDM2 binds to p53, inactivates p53 transcription function, inhibits p53 …

MDM2 promotes ubiquitination and degradation of MDMX

Y Pan, J Chen - Molecular and cellular biology, 2003 - Taylor & Francis
The p53 tumor suppressor is regulated by MDM2-mediated ubiquitination and degradation.
Mitogenic signals activate p53 by induction of ARF expression, which inhibits p53 …

Notch1 is required for Kras-induced lung adenocarcinoma and controls tumor cell survival via p53

S Licciulli, JL Avila, L Hanlon, S Troutman, M Cesaroni… - Cancer research, 2013 - AACR
The Notch pathway has been implicated in a number of malignancies with different roles that
are cell-and tissue-type dependent. Notch1 is a putative oncogene in non–small cell lung …

Low-dose radiation hypersensitivity is associated with p53-dependent apoptosis

L Enns, KT Bogen, J Wizniak, AD Murtha… - Molecular Cancer …, 2004 - AACR
Exposure to environmental radiation and the application of new clinical modalities, such as
radioimmunotherapy, have heightened the need to understand cellular responses to low …

[HTML][HTML] Knockdown of malic enzyme 2 suppresses lung tumor growth, induces differentiation and impacts PI3K/AKT signaling

JG Ren, P Seth, CB Clish, PK Lorkiewicz, RM Higashi… - Scientific reports, 2014 - nature.com
Abstract Mitochondrial malic enzyme 2 (ME2) catalyzes the oxidative decarboxylation of
malate to yield CO2 and pyruvate, with concomitant reduction of dinucleotide cofactor NAD+ …

Loss of tumor suppressor RPL5/RPL11 does not induce cell cycle arrest but impedes proliferation due to reduced ribosome content and translation capacity

T Teng, CA Mercer, P Hexley, G Thomas… - … and cellular biology, 2013 - Taylor & Francis
Humans have evolved elaborate mechanisms to activate p53 in response to insults that lead
to cancer, including the binding and inhibition of Hdm2 by the 60S ribosomal proteins (RPs) …

miR-34c may protect lung cancer cells from paclitaxel-induced apoptosis

S Catuogno, L Cerchia, G Romano, P Pognonec… - Oncogene, 2013 - nature.com
MicroRNAs (miRNAs) constitute a class of small non-coding RNAs that negatively regulate
the expression of their target genes. They are involved in many biological processes …